Study reveals association between ribosomal DNA copy number and disease risk

FHS
May 15, 2024
6:58 pm

Ribosomal DNA (rDNA) is present in hundreds of copies in the genome, but has not previously been part of genetic analyses.

Syros’ stock up almost 30% after positive early PhII data for blood cancer drug

Syros Pharmaceuticals’ drug candidate for hematological malignancies saw an increased complete response rate versus standard of care in a mid-stage acute myeloid leukemia trial, marking

December 7, 2023

5 takeaways from STAT’s look at unwanted supplies and surprise bills from device maker Zynex Medical

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies,

June 4, 2024

Mayo Clinic research shows health benefits of active workstations

A recent Mayo Clinic study suggests that active workstations incorporating a walking pad, bike, stepper and/or standing desk are successful strategies for reducing sedentary time

April 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.